Balanced news tone
News Sentiment
OPK sentiment intelligence
Opko Health Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
51
Balanced news tone
52 relevant articles
Price is moving more forcefully than the current news tone suggests.
79/100 classification confidence.
directly relevant articles
high-authority source matches
-11.2% over one week, -4.9% over four weeks, trend active, and near fair-value range.
OPK5733212 Bond Profile — Key Metrics
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Primary event
Market update
79/100 classification
One-week reaction
-11.2%
Price reacting lower
Trend fit
Trend active
-4.9% over four weeks
Fair value
-3.1%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
11
Neutral
37
Negative
4
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Insider Monkey
Direct company coverage
OPKO Health (OPK) Amends Partnership With Nicoya Therapeutics to Gain Equity Stake
- Tone
- Positive 58/100
- Event
- Deals and strategy
- Published
- 05 Jun 2026 21:57
- Source
- Insider Monkey
Market source
Direct company coverage
OPKO Health (OPK) Up 17.1% Since Last Earnings Report: Can It Continue?
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 28 May 2026 07:00
- Source
- Market source
Ad-hoc-news.de
Direct company coverage
OPKO Health stock (US68375N1037): earnings update keeps focus on pipeline and Rayaldee outlook
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 May 2026 07:00
- Source
- Ad-hoc-news.de
GlobeNewswire
Direct company coverage
OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 May 2026 12:00
- Source
- GlobeNewswire
simplywall.st
Direct company coverage
OPKO Health (OPK) Q1 Loss Of US$54.8 Million Tests Bullish Turnaround Narratives
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Apr 2026 07:00
- Source
- simplywall.st
OPKO Health, Inc.
Direct company coverage
OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 28 Apr 2026 07:00
- Source
- OPKO Health, Inc.
Market source
Direct company coverage
OPKO Health (OPK) Reports Q1 Loss, Misses Revenue Estimates
- Tone
- Negative 18/100
- Event
- Earnings
- Published
- 28 Apr 2026 07:00
- Source
- Market source
Market source
Direct company coverage
How The OPKO Health (OPK) Narrative Is Shifting After Mixed Results And A Lower Price Target
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 23 Apr 2026 07:00
- Source
- Market source
Market source
Direct company coverage
A Look Back at Health Insurance Providers Stocks’ Q4 Earnings: Alignment Healthcare (NASDAQ:ALHC) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 03 Apr 2026 07:00
- Source
- Market source
Market source
Direct company coverage
How The OPKO Health (OPK) Story Is Shifting With Mixed Analyst Signals
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 27 Mar 2026 07:00
- Source
- Market source
Seeking Alpha
Direct company coverage
OPKO Health: The Waiting Game Continues (NASDAQ:OPK)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Mar 2026 07:00
- Source
- Seeking Alpha
Market source
Direct company coverage
Danaher (DHR) Projects 2026 Revenue Growth at TD Cowen 46th Annual Health Care Conference
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 24 Mar 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Barrington Lowers PT on OPKO Health (OPK), Keeps a Buy
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 20 Mar 2026 07:00
- Source
- Market source
DirectorsTalk Interviews
Direct company coverage
Opko Health, Inc. (OPK) Stock Analysis: A Glimpse Into Potential 185% Upside
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 17 Mar 2026 07:00
- Source
- DirectorsTalk Interviews
Market source
Direct company coverage
Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 18 Feb 2026 08:00
- Source
- Market source
Market source
Direct company coverage
OPKO Health Insider Ups Holding During Year
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Feb 2026 08:00
- Source
- Market source
Seeking Alpha
Direct company coverage
OPKO Health: Deeply Mispriced Ahead Of Major Catalysts (NASDAQ:OPK)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Jan 2026 08:00
- Source
- Seeking Alpha
Investing.com
Direct company coverage
Opko Health CEO Phillip Frost buys $737,747 in OPK stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Nov 2025 08:00
- Source
- Investing.com
simplywall.st
Direct company coverage
Insider Buying: OPKO Health Chairman & CEO Bought US$213k Of Shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Nov 2025 08:00
- Source
- simplywall.st
Quiver Quantitative
Direct company coverage
OPKO Health, Inc. to Announce Q3 2025 Financial Results and Business Update on October 29, 2025
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 22 Oct 2025 07:00
- Source
- Quiver Quantitative
Market source
Direct company coverage
Here's Why You Should Retain OPKO Health Stock in Your Portfolio
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jun 2025 07:00
- Source
- Market source
OPKO Health, Inc.
Direct company coverage
OPKO Health Acquires ModeX Therapeutics, Gains Proprietary Immunotherapy Technology with a Focus on Oncology and Infectious Diseases
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 09 May 2022 07:00
- Source
- OPKO Health, Inc.